Literature DB >> 16041258

Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations.

Martin R Zamora1, R Duane Davis, Colm Leonard.   

Abstract

Cytomegalovirus (CMV) continues to cause significant morbidity and mortality in lung transplant recipients. This article presents recommendations based on available evidence for the optimal management of CMV in lung transplant recipients, which have been developed by an expert committee of transplant physicians-surgeons and infectious disease specialists.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16041258     DOI： 10.1097/01.tp.0000165430.65645.4f

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


  11 in total

1.  Introduction: disease overview and risk factors.

Authors: 
Journal:  P T       Date:  2010-03

Review 2.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

3.  Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients.

Authors:  Corinna La Rosa; Ajit P Limaye; Aparna Krishnan; Gideon Blumstein; Jeff Longmate; Don J Diamond
Journal:  Transpl Int       Date:  2011-06-14       Impact factor: 3.782

4.  Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States.

Authors:  Chitaru Kurihara; Ramiro Fernandez; Niloufar Safaeinili; Mahzad Akbarpour; Qiang Wu; G R Scott Budinger; Ankit Bharat
Journal:  Ann Thorac Surg       Date:  2018-11-23       Impact factor: 4.330

5.  Long term complications following 54 consecutive lung transplants.

Authors:  Walther Tabarelli; Hugo Bonatti; Dominique Tabarelli; Miriam Eller; Ludwig Müller; Elfriede Ruttmann; Cornelia Lass-Flörl; Clara Larcher; Christian Geltner
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

6.  Immune Monitoring of Infectious Complications in Transplant Patients: an Important Step towards Improved Clinical Management.

Authors:  Rajiv Khanna
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

Review 7.  Lung transplantation.

Authors:  José Eduardo Afonso Júnior; Eduardo de Campos Werebe; Rafael Medeiros Carraro; Ricardo Henrique de Oliveira Braga Teixeira; Lucas Matos Fernandes; Luis Gustavo Abdalla; Marcos Naoyuki Samano; Paulo Manuel Pêgo-Fernandes
Journal:  Einstein (Sao Paulo)       Date:  2015 Apr-Jun

8.  Clinical utilities of peripheral blood gene expression profiling in the management of cardiac transplant patients.

Authors:  Kenneth C Fang
Journal:  J Immunotoxicol       Date:  2007-07       Impact factor: 3.000

Review 9.  Cytomegalovirus infection in transplant recipients.

Authors:  Luiz Sergio Azevedo; Lígia Camera Pierrotti; Edson Abdala; Silvia Figueiredo Costa; Tânia Mara Varejão Strabelli; Silvia Vidal Campos; Jéssica Fernandes Ramos; Acram Zahredine Abdul Latif; Nadia Litvinov; Natalya Zaidan Maluf; Helio Hehl Caiaffa Filho; Claudio Sergio Pannuti; Marta Heloisa Lopes; Vera Aparecida dos Santos; Camila da Cruz Gouveia Linardi; Maria Aparecida Shikanai Yasuda; Heloisa Helena de Sousa Marques
Journal:  Clinics (Sao Paulo)       Date:  2015-07-01       Impact factor: 2.365

10.  Prophylaxis against pulmonary viral and fungal infections in solid organ transplant recipients.

Authors:  Anton Y Peleg; Mary T Lasalvia; Eleftherios Mylonakis; Fernanda P Silveira
Journal:  Curr Infect Dis Rep       Date:  2009-05       Impact factor: 3.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.